A lot of news on Portfolio holding of PSTI:

Thursday, August 16, 2012
2:30 AM Pluristem Receives Approval From Indian Ministry of Health for Use of PLX Cells in Phase II Trial for Treatment of Buerger’s Disease (GNW)

3:00 AM Pluristem Receives Approval to Commence a Phase I/II Study for Muscle Regeneration in Germany (GNW)

Monday, August 13, 2012
2:00 AM Pluristem Moves Intermittent Claudication Indication Forward in Europe Through Collaboration With Cato Research (GNW)

 

Leave a Reply

Your email address will not be published. Required fields are marked *